Blauvelt, A, RB Warren, K Reich, F Brock, F Fierens, V Ciaravino, and M Lebwohl. “Durability of DLQI Improvements Among Patients With Moderate to Severe Plaque Psoriasis Treated With Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s80. Accessed July 4, 2024. https://jofskin.org/33014/index.php/skin/article/view/1113.